68.43
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DXCM Giù?
Forum
Previsione
Frazionamento azionario
Dexcom Inc Borsa (DXCM) Ultime notizie
How DexCom Inc. stock compares to growth peersMarket Movement Recap & Low Risk High Reward Ideas - ulpravda.ru
Will DexCom Inc. stock benefit from sector rotationTrade Entry Summary & Reliable Breakout Stock Forecasts - ulpravda.ru
How DexCom Inc. stock performs in weak economyTake Profit & Safe Capital Growth Stock Tips - ulpravda.ru
Dexcom Finishes Off Class Claims Over Sales Growth Statements - Bloomberg Law News
DexCom (DXCM) Stock Trades Down, Here Is Why - Finviz
Why DexCom Inc. stock is rated strong buyTreasury Yields & Reliable Volume Spike Trade Alerts - ulpravda.ru
Published on: 2026-01-08 22:18:15 - ulpravda.ru
Is DexCom Inc. stock a good choice for value investorsVolume Spike & Short-Term Trading Opportunity Alerts - ulpravda.ru
Dexcom CEO Jake Leach Takes the Helm, Presents Future at CES - Medical Product Outsourcing
Dexcom enters next era of continued innovation with Jake Leach as chief executive officer - MarketScreener
Dexcom CEO Jake Leach begins tenure with focus on metabolic health By Investing.com - Investing.com South Africa
Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer - DexCom Investor Relations
Is DexCom, Inc.'s (NASDAQ:DXCM) Recent Stock Performance Tethered To Its Strong Fundamentals? - 富途牛牛
DexCom Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
UBS (AMUB) DexCom-linked trigger autocallable notes detail coupons and downside risk - Stock Titan
Dexcom Inc. Bets Big on Continuous Glucose Monitoring — and It’s Winning - AD HOC NEWS
Why pension funds invest in DexCom Inc. (DC4) stock2026 world cup usa national team qualification defensive leaders high defensive line knockout prediction preview - ulpravda.ru
DexCom Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
How DexCom Inc stock performs in weak economy2025 Performance Recap & AI Enhanced Trading Signals - moha.gov.vn
Dexcom names Jacob Leach as incoming chief executive - MSN
Assessing DexCom (DXCM) Valuation As Shares Lag Over The Past Year - Yahoo Finance
DexCom, Inc.'s (NASDAQ:DXCM) Stock Been Rising: Are Strong Financials Guiding The Market? - Yahoo Finance
Who Owns Dexcom? Top Shareholders and Recent Insider Trades - TIKR.com
DexCom, Inc. $DXCM Shares Sold by Ethic Inc. - Defense World
Dexcom Stock in Focus: Quiet Rally, Mixed Signals and a Data?Driven Bet on Connected Diabetes Care - AD HOC NEWS
DexCom Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Mobile Health (mHealth) Technologies and Global Markets Report 2025-2030 Featuring Leading CompaniesApple, Samsung, AT&T, Medtronic, Abbott, Koninklijke Philips N.V., and DexcomResearchAndMarkets.com - The AI Journal
DexCom Inc Stock Price Live, Charts & News - The Economic Times
The Truth About DexCom Inc: Why Everyone Is Suddenly Watching DXCM - AD HOC NEWS
3 Stocks Likely to Gain From Rising HSA Contribution & Medicare Premium - TradingView — Track All Markets
DexCom Inc (NASDAQ:DXCM) Embodies the Growth at a Reasonable Price (GARP) Strategy - Chartmill
DexCom (NASDAQ:DXCM) & Avanos Medical (NYSE:AVNS) Head-To-Head Contrast - Defense World
Dexcom Stock Finds Its Range: What The Latest Drift, Data, And Deals Signal For 2026 - AD HOC NEWS
FDA says Dexcom issues correction for Dexcom G6 and G6 Pro software - marketscreener.com
E. Ohman J or Asset Management AB Raises Position in DexCom, Inc. $DXCM - MarketBeat
SWS Partners Purchases 19,073 Shares of DexCom, Inc. $DXCM - MarketBeat
Beacon Investment Advisory Services Inc. Trims Stock Position in DexCom, Inc. $DXCM - Defense World
Class Action Alert: Levi & Korsinsky Reminds DexCom (DXCM) Investors of December 26, 2025 Deadline - ACCESS Newswire
Recover Investment Losses: Class Action Initiated Against DexCom, Inc. (DXCM) - ACCESS Newswire
DexCom, Inc. Sued for Securities Law Violations – Investors - GlobeNewswire
DexCom, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before December 26, 2025 to Discuss Your RightsDXCM - Finviz
DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, - GlobeNewswire
DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm - GlobeNewswire Inc.
DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
DXCM DEADLINEFINAL REMINDER: Bronstein, Gewirtz & Grossman LLC Alerts DexCom, Inc. Investors to Participate in the Class Action Lawsuit - ACCESS Newswire
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Levi & Korsinsky Urges DexCom (DXCM) Shareholders to Act Before Lead Plaintiff Deadline December 26, 2025 - ACCESS Newswire
Lost Money on DexCom, Inc. (DXCM)? Join Class Action Before December 26, 2025Contact Levi & Korsinsky - ACCESS Newswire
December 26, 2025 Deadline: Join Class Action Lawsuit Against DexCom, Inc. (DXCM)Contact Levi & Korsinsky - ACCESS Newswire
Securities Lawsuit Alert: DexCom, Inc. (DXCM) InvestorsContact Levi & Korsinsky Before December 26, 2025 - ACCESS Newswire
DAVENPORT & Co LLC Increases Position in DexCom, Inc. $DXCM - MarketBeat
Lost Money on DexCom, Inc. (DXCM)? Urged to Join Class Action Before December 26, 2025Contact Levi & Korsinsky - ACCESS Newswire
DXCM ALERT: Securities Fraud Class Action Launched Against DexCom, Inc.December 26, 2025 Deadline - ACCESS Newswire
Investor Alert: Deadline Approaching to Join DexCom, Inc. (DXCM) Class ActionContact Levi & Korsinsky - ACCESS Newswire
Class Action Lawsuit Filed: DexCom, Inc. (DXCM)Join by December 26, 2025Contact Levi & Korsinsky - ACCESS Newswire
DXCM DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds DexCom, Inc. Investors to Join the Class Action Lawsuit - ACCESS Newswire
Voya Investment Management LLC Sells 186,132,582 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom (DXCM): Reassessing Valuation After Class Action Lawsuits and New FDA Clearance for Smart Basal - Sahm
DXCM Investors Have Opportunity to Lead DexCom, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
An Intrinsic Calculation For DexCom, Inc. (NASDAQ:DXCM) Suggests It's 47% Undervalued - 富途牛牛
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT - GuruFocus
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):